Fundz
New|Fundz now works inside Claude2 min

Timing. Relevance. Relationships.

Fundz is the only platform that reads more than a dozen real‑time signals all day, every day, so you know about new funding, new executives and new contracts within minutes of them happening, not days or weeks later like the databases you’re used to. It then combines the signals on each company, scores every company against what you offer, and weaves in your own network, so you discover new accounts first and work existing ones better.

Each morning you get the ones worth your time right now: who to reach, why now, and who you already know there. Now it answers in Claude too: ask for today’s leads, then write the note in the same window.

Trusted by

OracleSnowflakeCloudflareLinkedInGoogleSalesforce
4.8/5 on G2· Since 2015
Back to SEC Filings
Material AgreementItem 1.01 · 8-KLOW RiskPositive

SCYNEXIS, Inc.

The company signed a major contract or deal. An 8-K is the notice a US public company must file within four business days of a major event.

www.scynexis.com
Filed: Sep 25, 2026Jersey City, New JerseyCIK: 0001178253Health Care
Full company profileView on SEC.gov

AI Executive Summary

AI-powered analysis of 8-K filing content

SCYNEXIS secured up to $214 million in non-dilutive funding from BARDA to develop SCY-247, an antifungal candidate, with an initial $18.5 million allocation for Phase 2 studies in invasive candidiasis. This strategic partnership significantly de-risks the company's clinical development pathway and provides substantial capital without equity dilution.

Key Takeaways

BARDA contract provides up to $214 million in non-dilutive funding, eliminating near-term financing pressure and reducing shareholder dilution risk

Initial $18.5 million funds advancement of SCY-247 into Phase 2 study for invasive candidiasis, a high-unmet-need indication

2 more takeaways

Related Filings (1)

1 more filing from SCYNEXIS, Inc. in the last 90 days

Filing Overview

Form Type8-K
Filing DateSep 25, 2026
Item1.01
CategoryMaterial Agreement
CIK0001178253
Accession #0001178253-26-000037
Risk LevelLOW
SentimentPositive
Signalopportunity
Topics
material agreementpartnershipregulatory

What This Means

The company entered into a significant agreement that could materially affect its business. This often signals new partnerships, licensing deals, or major contracts.
View Full Filing on SEC.govBrowse More Filings

SCYNEXIS, Inc. filed with the SEC. Fundz turns 8-K material events into an alert with the right executive attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

4 screens from a live account. No signup.